Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Semaglutide reduces alcohol intake and relapse-like drinking in male and female rats
Cajsa Aranäs, Christian E. Edvardsson, Olesya T. Shevchouk, et al.
EBioMedicine (2023) Vol. 93, pp. 104642-104642
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zhikai Zheng, Zong Yao, Yiyang Ma, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 88
Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity
Fatima Quddos, Zachary Hubshman, Allison N. Tegge, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 55
Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 Diabetes
Lindsey Wang, Nathan A. Berger, David C. Kaelber, et al.
Gastroenterology (2024) Vol. 167, Iss. 4, pp. 689-703
Open Access | Times Cited: 37
Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population
William Wang, Nora D. Volkow, Nathan A. Berger, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 29
Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real-world populations: a retrospective cohort study
William Yang Wang, Nora D. Volkow, Nathan A. Berger, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 8, pp. 2587-2598
Open Access | Times Cited: 24
Management of alcohol use disorder: a gastroenterology and hepatology-focused perspective
Luis Antonio Díaz, Daniel König, Sabine Weber, et al.
˜The œLancet. Gastroenterology & hepatology (2025)
Closed Access | Times Cited: 3
Once-Weekly Semaglutide in Adults With Alcohol Use Disorder
Christian S. Hendershot, Michael P. Bremmer, Michael B. Paladino, et al.
JAMA Psychiatry (2025)
Closed Access | Times Cited: 2
GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders
Lorenzo Leggio, Christian S. Hendershot, Mehdi Farokhnia, et al.
Nature Medicine (2023) Vol. 29, Iss. 12, pp. 2993-2995
Closed Access | Times Cited: 38
Progress is impossible without change: understanding the evolving nomenclature of steatotic liver disease and its effect on hepatology practice
Paul Brennan, Oliver Tavabie, Wenhao Li, et al.
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 6, pp. 577-582
Open Access | Times Cited: 11
Effect of the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide on alcohol consumption in alcohol-preferring male vervet monkeys
Anders Fink‐Jensen, Gitta Wörtwein, Mette Kruse Klausen, et al.
Psychopharmacology (2024)
Open Access | Times Cited: 11
Repurposing Semaglutide and Liraglutide for Alcohol Use Disorder
Markku Lähteenvuo, Jari Tiihonen, Anssi Solismaa, et al.
JAMA Psychiatry (2024)
Closed Access | Times Cited: 9
Does semaglutide reduce alcohol intake in Danish patients with alcohol use disorder and comorbid obesity? Trial protocol of a randomised, double-blinded, placebo-controlled clinical trial (the SEMALCO trial)
Mette Kruse Klausen, Tugba Kuzey, Jens Pedersen, et al.
BMJ Open (2025) Vol. 15, Iss. 1, pp. e086454-e086454
Open Access | Times Cited: 1
Impact of GLP‐1 Receptor Agonists on Alcohol‐Related Liver Disease Development and Progression in Alcohol Use Disorder
Chia‐Chih Kuo, Chun‐Hsien Li, Min‐Hsiang Chuang, et al.
Alimentary Pharmacology & Therapeutics (2025)
Open Access | Times Cited: 1
An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders
Riccardo De Giorgi, Ana Ghenciulescu, Oliwia Dziwisz, et al.
Nature Mental Health (2025)
Open Access | Times Cited: 1
Enteroendocrine cell regulation of the gut-brain axis
Joshua R. Barton, Anne Londregan, Tyler D. Alexander, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 19
Effects of dulaglutide on alcohol consumption during smoking cessation
Leila Probst, Sophie Monnerat, D. Vogt, et al.
JCI Insight (2023) Vol. 8, Iss. 22
Open Access | Times Cited: 19
New insights into the molecular basis of alcohol abstinence and relapse in alcohol-associated liver disease
Luis Antonio Díaz, Gerald Scott Winder, Lorenzo Leggio, et al.
Hepatology (2023)
Closed Access | Times Cited: 18
Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder
Sophie Köhne, Thomas Hillemacher, Alexander Glahn, et al.
Expert Opinion on Emerging Drugs (2024) Vol. 29, Iss. 3, pp. 219-232
Closed Access | Times Cited: 6
Novel medications for problematic alcohol use
Markus Heilig, Katie Witkiewitz, Lara A. Ray, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 11
Open Access | Times Cited: 6
IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target
Nicolaus Bruns, Elizabeth H. Tressler, Leandro F. Vendruscolo, et al.
Pharmacological Research (2024) Vol. 207, pp. 107312-107312
Open Access | Times Cited: 6
GLP-1 agonists and risk of suicidal thoughts and behaviours: Confound by indication once again? A narrative review
Robertas Strumila, Aistė Lengvenytė, Sebastien Guillaume, et al.
European Neuropsychopharmacology (2024) Vol. 87, pp. 29-34
Open Access | Times Cited: 6
Social media as pharmacovigilance: The potential for patient reports to inform clinical research on glucagon-like peptide 1 (GLP-1) receptor agonists for substance use disorders
Michael P. Bremmer, Christian S. Hendershot
Journal of Studies on Alcohol and Drugs (2023)
Closed Access | Times Cited: 14
Short-term effects of semaglutide among patients with obesity with and without food addiction: an observational study
Joana Nicolau, María Isabel Tamayo, Pilar Sanchís, et al.
Journal of Addictive Diseases (2024) Vol. 42, Iss. 4, pp. 535-543
Closed Access | Times Cited: 5
What Is Food Noise? A Conceptual Model of Food Cue Reactivity
Daisuke Hayashi Neto, Caitlyn G. Edwards, Jennifer A. Emond, et al.
Nutrients (2023) Vol. 15, Iss. 22, pp. 4809-4809
Open Access | Times Cited: 12
A critical review of ethanol effects on neuronal firing: A metabolic perspective
Dina Popova, Jacquelyne Ka‐Li Sun, Hei‐Man Chow, et al.
Alcohol Clinical and Experimental Research (2024) Vol. 48, Iss. 3, pp. 450-458
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top